These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8701909)

  • 1. Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
    Cohen MB; Snow JS; Merkatz KA; Kholwadwala D; Jadonath RL; Goldner BG; Cohen TJ
    Am Heart J; 1996 Aug; 132(2 Pt 1):446-9. PubMed ID: 8701909
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ
    Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of ventricular arrhythmias].
    Hohnloser SH
    Med Klin (Munich); 1997 Apr; 92(4):208-10. PubMed ID: 9221302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sotalol on RR interval variability during induced ventricular tachycardia.
    Yli-Mäyry S; García-Alberola A; Haverkamp W; Hindricks G; Martínez-Rubio A; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Aug; 78(3):372-6. PubMed ID: 8759826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiffel JA; Hahn E; Hartz V; Reiter MJ
    Am J Cardiol; 1997 Apr; 79(8):1048-53. PubMed ID: 9114762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A perspective on the ESVEM trial current knowledge: sotalol should not be the first-line agent in the management of ventricular arrhythmias.
    Garan H
    Prog Cardiovasc Dis; 1996; 38(6):455-6. PubMed ID: 8638026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
    Campbell RW; Furniss SS
    Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the effect of D,L-sotalol on ventricular tachycardia inducibility from the RR variability response.
    Brembilla-Perrot B; Houriez P; Claudon O; Preiss JP; Beurrier D
    Heart; 1999 Sep; 82(3):307-11. PubMed ID: 10455080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent fascicular ventricular tachycardia in myotonic dystrophy.
    Nageh MF
    Europace; 2006 May; 8(5):336-7. PubMed ID: 16635990
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias.
    Reiffel JA
    Am Heart J; 1999 Feb; 137(2):372-3. PubMed ID: 10049191
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ventricular Tachycardia as a First Manifestation of Myotonic Dystrophy].
    Mironov NY; Mironova NA; Sokolov SF; Mareev YV; Shlevkov NB; Saidova MA; Stukalova OV; Golitsyn SP
    Kardiologiia; 2015; 55(8):86-96. PubMed ID: 26761978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB
    J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
    [No Abstract]   [Full Text] [Related]  

  • 14. Proarrhythmias and antiarrhythmias: two sides of the same coin.
    Kowey PR; Yan GX
    Heart Rhythm; 2005 Sep; 2(9):957-9. PubMed ID: 16171750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
    Kovoor P; Eipper V; Byth K; Cooper MJ; Uther JB; Ross DL
    Eur Heart J; 1999 Mar; 20(5):364-74. PubMed ID: 10206383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade.
    Nanthakumar K; Newman D; Paquette M; Greene M; Rakovich G; Dorian P
    Am Heart J; 1997 Oct; 134(4):752-7. PubMed ID: 9351744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and efficacy testing of sotalol.
    Mason JW
    J Am Coll Cardiol; 1999 Jan; 33(1):53-4. PubMed ID: 9935008
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of telemetered permanent pacemaker intracardiac electrograms to diagnose ventricular tachycardia.
    Ganz LI; Couper GS; Friedman PL; Stevenson WG; Ellison K
    Am J Cardiol; 1997 Dec; 80(11):1511-3. PubMed ID: 9399739
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.